Oncology Clinical Research and Pharmacy

The scope of oncology research is often high, and the complexity of clinical trial designs and study designs is increasing. Reports currently show that the success rate of investigational compounds approved for clinical use in cancer is the lowest of any disease, and only 6.7% are thought to be approved for these diseases. Cancer drugs are being studied in Phase I studies. In oncology, there are key differences in clinical trials.

  • Subtypes of Cancer
  • Creation of data from oncology studies
  • Systematic appraisal

Mail us at

Program Enquiry
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2023-2024 Allied Academies, All Rights Reserved.